BioCentury
ARTICLE | Company News

Aeterna Zentaris, Merck KGaA deal

October 7, 2013 7:00 AM UTC

Aeterna completed the transfer of manufacturing rights for Cetrotide cetrorelix acetate in vitro fertilization (IVF) to marketing partner Merck Serono S.A., a division of Merck, in exchange for €2.5...